FDA Approves New CAR-T Therapy for Multiple Myeloma

The approval could open the door to more Western pharmaceutical companies looking to bring China-developed therapies to the U.S.

Multiple myeloma, aka Kahler’s disease, is a cancer that forms in a type of white blood cell called a plasma cell, and inhibits their ability to fight infection. The American Cancer Society estimates it causes more than 12,400 deaths in the U.S. each year. Prior to this week, there was only one therapy available, which caused supply issues. A recent article from The Wall Street Journal discussed the FDA’s approval of a second CAR-T cancer therapy to treat multiple myeloma.

Pharmaceutical Innovations Report
Discover the latest breakthrough packaging technologies shaping the pharmaceutical sector. This report dives into cutting-edge innovations, from smart containers that enhance patient safety to eco-friendly materials poised to transform the industry’s sustainability practices. All from PACK EXPO. Learn how forward-thinking strategies are driving efficiency and redefining what’s possible in pharma packaging.
Learn More
Pharmaceutical Innovations Report
List: Digitalization Companies From PACK EXPO
Looking for CPG-focused digital transformation solutions? Download our editor-curated list from PACK EXPO featuring top companies offering warehouse management, ERP, digital twin, and MES software with supply chain visibility and analytics capabilities—all tailored specifically for CPG operations.
Download Now
List: Digitalization Companies From PACK EXPO